Hospital de Cruces

Running trials

• Not yet recruiting

  Optimizing the Use of Aspirin for the Prevention of Preeclampsia

  NCT07665853· Phase 3· Hospital Universitari Vall d'Hebron Research Institute· Source

• Recruiting

  Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

  NCT07585890· University Medical Center Groningen· Source

• Recruiting

  A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

  NCT07284121· Hoffmann-La Roche· Source

• Recruiting

  Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

  NCT07717268· Phase 2· Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  NCT06143878· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  NCT05776472· Swedish Orphan Biovitrum· Source

• Recruiting

  Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

  NCT05781217· Phase 3· Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic· Source

• Recruiting

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03596645· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

  NCT03569241· Phase 2· University Hospital, Ghent· Source

• Recruiting

  HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

  NCT02855476· University College, London· Source

• Recruiting

  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  NCT01574053· CHDI Foundation, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer2 recruiting
• Lung cancer2 recruiting
• Head and neck cancer1 recruiting
• Huntington's disease1 recruiting
• Liver cirrhosis1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

  NCT06615921· Takeda· Source

• Completed

  Prospective, Multicentre Study to Evaluate the Thrombectomy System for Stroke: iNedit, iNdeep and iNtercept

  NCT05893719· iVascular S.L.U.· Source

• Completed

  Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease

  NCT05192616· iVascular S.L.U.· Source

• Completed

  A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

  NCT05122650· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  AI-based Medical Device Validation for Early Melanoma Detection

  NCT06221397· AI Labs Group S.L· Source

• Completed

  Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

  NCT06031038· Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

  NCT03976349· Phase 1· Ionis Pharmaceuticals, Inc.· Source

• Completed

  A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

  NCT03371017· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Neurovascular Product Surveillance Registry

  NCT02988128· Medtronic Neurovascular Clinical Affairs· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cushing's syndrome4 works · 0 trials